Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
1965 2
1974 1
1975 1
1976 4
1977 3
1978 1
1979 4
1980 2
1981 10
1982 3
1983 12
1984 10
1985 12
1986 10
1987 8
1988 13
1989 16
1990 15
1991 11
1992 13
1993 15
1994 13
1995 26
1996 24
1997 15
1998 23
1999 27
2000 30
2001 25
2002 29
2003 29
2004 28
2005 34
2006 28
2007 24
2008 27
2009 30
2010 42
2011 29
2012 26
2013 25
2014 46
2015 40
2016 50
2017 49
2018 72
2019 76
2020 76
2021 88
2022 87
2023 79
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

1,245 results

Results by year

Filters applied: . Clear all
Page 1
Novel cancer therapy targeting microbiome.
Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y. Nagano T, et al. Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190864 Free PMC article. Review.
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and End-Stage Renal Disease.
Nishimura M, Hsu JC. Nishimura M, et al. Am J Cardiol. 2018 Jan 1;121(1):131-140. doi: 10.1016/j.amjcard.2017.09.030. Epub 2017 Oct 12. Am J Cardiol. 2018. PMID: 29132650 Review.
Over the past decade, there have been tremendous advancements in anticoagulation therapies for stroke prevention in patients with atrial fibrillation (AF). Although the non-vitamin K antagonist oral anticoagulants (NOACs) demonstrated favorable clinical outcomes compared w …
Over the past decade, there have been tremendous advancements in anticoagulation therapies for stroke prevention in patients with atrial fib …
Future Prospects of Onco-Hypertension.
Minegishi S, Nishiyama A, Yano Y, Node K; JSH Working Group Onco-Hypertension. Minegishi S, et al. Hypertension. 2023 Jul;80(7):e123-e124. doi: 10.1161/HYPERTENSIONAHA.123.21011. Epub 2023 May 11. Hypertension. 2023. PMID: 37315121 No abstract available.
Vertebrate female germline--the acquisition of femaleness.
Tanaka M. Tanaka M. Wiley Interdiscip Rev Dev Biol. 2014 May-Jun;3(3):231-8. doi: 10.1002/wdev.131. Epub 2013 Nov 26. Wiley Interdiscip Rev Dev Biol. 2014. PMID: 24896659 Review.
Recent work has revealed the presence of germline stem cells in the vertebrate ovary, using the teleost fish, medaka (Oryzias latipes) (Nakamura S, Kobayashi K, Nishimura T, Higashijima S, Tanaka, M. Identification of germline stem cells in the ovary of teleost meda …
Recent work has revealed the presence of germline stem cells in the vertebrate ovary, using the teleost fish, medaka (Oryzias latipes) (Naka …
Agonist-induced vascular tone.
Nishimura J, Khalil RA, van Breemen C. Nishimura J, et al. Hypertension. 1989 Jun;13(6 Pt 2):835-44. doi: 10.1161/01.hyp.13.6.835. Hypertension. 1989. PMID: 2544524 Review.
However, the measurement of intracellular Ca2+ concentration during the sustained phase of agonist-induced contraction is reported to be lower than that of high K+ stimulation or the value obtained by the experiments with chemically skinned smooth muscle preparations. ...
However, the measurement of intracellular Ca2+ concentration during the sustained phase of agonist-induced contraction is reported to be low …
1,245 results